3 counted as startup funding. Open the number of investors for the round's details.
18 investors had bought by the notice of Oct 1, 2025: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
No one: the notice names no broker or finder paid to sell it.
Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Oct 1, 2025. Read the notice at the SEC.
20 investors had bought by the notice of Sep 20, 2017: 20 accredited, none not accredited.
Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Sep 20, 2017. Read the notice at the SEC.
97 investors had bought by the notice of Feb 5, 2020: 97 accredited, none not accredited.
Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Feb 5, 2020 (1 amendment). Read the notice at the SEC.
What its filings and its own website say, sentence by sentence, each with its source.
BirchBioMed Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2025).
SEC Form D · Oct 2025
The industry group it chose in its notices: Biotechnology.
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
No investor of BirchBioMed Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
As the company named them in its notices. Directors of a funded startup are often partners of its investors.